An Investigation into the Resistance of Spherical Nucleic Acids against DNA Enzymatic Degradation

Author(s):  
Maria-Eleni Kyriazi ◽  
Afaf H. El-Sagheer ◽  
Igor L. Medintz ◽  
Tom Brown ◽  
Antonios G. Kanaras
2021 ◽  
Vol 143 (3) ◽  
pp. 1296-1300
Author(s):  
Yang Fang ◽  
Xueguang Lu ◽  
Dali Wang ◽  
Jiansong Cai ◽  
Yuyan Wang ◽  
...  

ACS Nano ◽  
2021 ◽  
Author(s):  
Ziyin N. Huang ◽  
Cassandra E. Callmann ◽  
Lisa E. Cole ◽  
Shuya Wang ◽  
Chad A. Mirkin

Author(s):  
Vijay Gulumkar ◽  
Antti Äärelä ◽  
Olli Moisio ◽  
Jani Rahkila ◽  
Ville Tähtinen ◽  
...  

2020 ◽  
Vol 13 (11) ◽  
pp. 360
Author(s):  
Thomas R. Holmes ◽  
Amy S. Paller

Spherical nucleic acids (SNAs) are nanostructures consisting of nucleic acids in a spherical configuration, often around a nanoparticle core. SNAs are advantageous as gene-regulating agents compared to conventional gene therapy owing to their low toxicity, enhanced stability, uptake by virtually any cell, and ability to penetrate the epidermal barrier. In this review we: (i) describe the production, structure and properties of SNAs; (ii) detail the mechanism of SNA uptake in keratinocytes, regulated by scavenger receptors; and (iii) report how SNAs have been topically applied and intralesionally injected for skin disorders. Specialized SNAs called nanoflares can be topically applied for gene-based diagnosis (scar vs. normal tissue). Topical SNAs directed against TNFα and interleukin-17A receptor reversed psoriasis-like disease in mouse models and have been tested in Phase 1 human trials. Furthermore, SNAs targeting ganglioside GM3 synthase accelerate wound healing in diabetic mouse models. Most recently, SNAs targeting toll-like receptor 9 are being used in Phase 2 human trials via intratumoral injection to induce immune responses in Merkel cell and cutaneous squamous cell carcinoma. Overall, SNAs are a valuable tool in bench-top and clinical research, and their advantageous properties, including penetration into the epidermis after topical delivery, provide new opportunities for targeted therapies.


Science ◽  
2015 ◽  
Vol 349 (6253) ◽  
pp. 1150-1151 ◽  
Author(s):  
Robert F. Service

2019 ◽  
Vol 127 ◽  
pp. 85-91 ◽  
Author(s):  
Lu Wang ◽  
Huan Zhang ◽  
Chenguang Wang ◽  
Yi Xu ◽  
Jing Su ◽  
...  

Aggregate ◽  
2021 ◽  
Author(s):  
Yangmeihui Song ◽  
Wenyu Song ◽  
Xiaoli Lan ◽  
Weibo Cai ◽  
Dawei Jiang

Sign in / Sign up

Export Citation Format

Share Document